These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1851586)
1. [The distribution of HLA-system antigens in lung cancer patients]. Levin VI; Muravskaia GV; Buglova EE; Semenov GV; Shavlikova LA; Surovikina VV; Sinaĭko VV Vopr Onkol; 1991; 37(3):280-3. PubMed ID: 1851586 [TBL] [Abstract][Full Text] [Related]
2. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters. Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207 [TBL] [Abstract][Full Text] [Related]
3. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy]. Tatsuno I; Konishi K Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796 [No Abstract] [Full Text] [Related]
4. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen]. Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198 [TBL] [Abstract][Full Text] [Related]
5. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment. Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911 [TBL] [Abstract][Full Text] [Related]
6. [Using two monoclonal antibodies to detect lung carcinoma associated antigen in the sera of patients with lung cancer by BA-ELISA]. Xue W; Hou J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):63-7. PubMed ID: 1652380 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer]. Letanche G; Ogier I; Weynants P; Hartmann DJ; Ville G; Cordier JF; Brune J Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207 [TBL] [Abstract][Full Text] [Related]
8. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer. Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins and complement components levels in patients with lung cancer. Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139 [TBL] [Abstract][Full Text] [Related]
10. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
11. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment. Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405 [TBL] [Abstract][Full Text] [Related]
12. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer. Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618 [TBL] [Abstract][Full Text] [Related]
13. The relative radioresponsiveness of small cell lung cancer. Ampil FL Radiat Med; 1988; 6(6):282-4. PubMed ID: 2854900 [TBL] [Abstract][Full Text] [Related]
14. [Relation between serum carcinoembryonic antigen (CEA) level and microscopic features of lung cancer]. Ochnio J; Szymańska D; Kwiek S; Rogińska E; Rowińska-Zakrzewska E Pneumonol Pol; 1984 Jul; 52(7):331-9. PubMed ID: 6093067 [No Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen fraction in lung cancer. Fong S; Leon V; Betancourt M; Guarnaluse R Neoplasma; 1983; 30(4):449-55. PubMed ID: 6310423 [TBL] [Abstract][Full Text] [Related]
16. HLA antigens and bronchogenic carcinoma in the Greek population. Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063 [TBL] [Abstract][Full Text] [Related]
17. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer]. Kozielski J; Seweryn J Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292 [No Abstract] [Full Text] [Related]
18. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy]. Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246 [TBL] [Abstract][Full Text] [Related]
19. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung]. Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044 [TBL] [Abstract][Full Text] [Related]
20. [Dose multifractionation in radiotherapy of lung cancer of different histological types]. Leskov VP; Mardynskiĭ IuS Med Radiol (Mosk); 1987 Jul; 32(7):30-3. PubMed ID: 3039285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]